Tirzepatide (Injectable) in San Francisco, CA
Doctor-prescribed Tirzepatide (Injectable) for San Francisco residents. Reviewed by licensed California physicians, compounded at FDA-registered pharmacies, and shipped straight to your door in San Francisco — no clinic visit required.
— All-in monthly price
No membership fee · this is the full price · free shipping · avg 4-week supply
available — pay over time at checkout— Add in-depth bloodwork
If your physician requires bloodwork and you don't have recent labs, an at-home panel is $129 — or get bloodwork done anywhere (your doctor, a lab, or insurance) and upload it — labs from the past 18 months work, at no charge.
Your sex-hormone baseline plus the safety markers that matter on therapy — blood counts, liver and kidney function — from one painless upper-arm device. Matched to your sex (PSA for men; progesterone & FSH for women). No needle, no clinic, physician-reviewed.
This treatment requires licensed provider review and approval. Treatment is not guaranteed. If prescribed, medication is fulfilled by a licensed U.S. pharmacy where permitted by law. Compounded medications are not FDA-approved or FDA-cleared.
About Tirzepatide (Injectable)
Dual GIP and GLP-1 receptor agonist offering enhanced weight management benefits.
How it works
Tirzepatide is a dual GIP/GLP-1 receptor agonist — it activates both incretin pathways instead of just one. This dual action produces superior weight loss results vs semaglutide alone. Phase 3 trials showed up to 22.5% body weight loss.
Clinical evidence
The SURMOUNT-1 trial (Jastreboff et al., NEJM 2022) randomized 2,539 adults with obesity to tirzepatide 5/10/15 mg vs placebo. At 72 weeks, mean weight reductions were 15.0%, 19.5%, and 20.9% on the active arms vs 3.1% on placebo — the highest weight-loss outcomes recorded for a pharmacological intervention at the time. SURMOUNT-2 confirmed efficacy in patients with type 2 diabetes, and the SURPASS program (Frias et al., 2021) demonstrated superior HbA1c reduction vs semaglutide head-to-head. Tirzepatide's dual GIP+GLP-1 mechanism appears to drive both stronger appetite suppression and improved metabolic flexibility.
Benefits
How it works in San Francisco
- Complete a free online intake (~5 minutes).
- A licensed California physician reviews your case within 24 hours.
- If approved, your prescription ships from our FDA-registered compounding pharmacy.
- Free shipping arrives in San Francisco 2–4 business days later. Refills ship automatically when your supply runs out — cancel anytime.
Tirzepatide (Injectable) vs. Mounjaro / Zepbound
Compounded at an FDA-registered 503A pharmacy. Compounded medications are not FDA-approved.
Tirzepatide (Injectable) for San Francisco patients
San Francisco — the heart of the Bay Area — is home to roughly 810K residents. Pepti serves San Francisco and the surrounding California area through licensed California physicians — and is available in all 50 states and Washington, D.C. California permits telehealth prescribing under Medical Board of California telehealth guidance. A California-licensed physician can establish the patient relationship through online intake review — no in-person visit is required for peptide or GLP-1 prescribing.
San Francisco sits in one of the fastest-growing GLP-1 telehealth markets in the country. The CDC puts adult obesity prevalence in California at 26.0% (CDC 2023), and physician-supervised metabolic care is increasingly how California patients address it. Pepti brings that care to San Francisco without a clinic visit — intake, physician review, and pharmacy fulfillment all happen online.
California patients show strong demand for longevity, performance, and metabolic peptide therapy delivered via telehealth.
The CDC reports 26.0% (CDC 2023) adult obesity prevalence in California. Tirzepatide (Injectable) is prescribed to San Francisco patients when BMI thresholds and intake criteria are met under physician review.
Dosing
Your prescribing physician determines the right dose, schedule, and how it's administered — based on your goals, medical history, and lab work. Your personalized protocol is provided after your consultation.
Important safety information
+
Possible side effects
Do not use if you have
If you experience severe side effects, call 911 or go to your nearest emergency room.
Frequently asked
in San Francisco.
Can I get Tirzepatide (Injectable) prescribed in San Francisco?
Yes. San Francisco residents can get Tirzepatide (Injectable) prescribed online by a physician licensed in California, with no in-person visit. Your prescription is compounded at an FDA-registered pharmacy and shipped to San Francisco. California permits telehealth prescribing under Medical Board of California telehealth guidance. A California-licensed physician can establish the patient relationship through online intake review — no in-person visit is required for peptide or GLP-1 prescribing.
How long does delivery take to San Francisco?
Orders ship from our FDA-registered compounding pharmacy within 1–3 business days of physician approval and typically arrive in San Francisco 2–4 business days after shipment. Shipping is free to every San Francisco address.
Do I need to visit a clinic in San Francisco?
No. Pepti is fully telehealth — San Francisco patients complete the entire process online, from intake to refills. California permits telehealth prescribing under Medical Board of California telehealth guidance. A California-licensed physician can establish the patient relationship through online intake review — no in-person visit is required for peptide or GLP-1 prescribing.
How much does Tirzepatide (Injectable) cost in San Francisco?
Tirzepatide (Injectable) starts at $179 at Pepti. Pepti is subscription-based — your refill ships when your supply runs out, and you can cancel anytime. Pricing is the same in San Francisco as everywhere else — no city or California markup, and shipping is included.
Is Pepti available outside San Francisco?
Yes — Pepti is available in all 50 states and Washington, D.C. Wherever you are in the country, a physician licensed in your state reviews your intake and your medication ships from an FDA-registered compounding pharmacy.
Is GLP-1 weight loss available near San Francisco?
Yes. With an adult obesity prevalence of 26.0% (CDC 2023) in California, GLP-1 therapy is increasingly standard care. San Francisco patients with BMI ≥ 30 (or ≥ 27 with weight-related conditions) can be prescribed Tirzepatide (Injectable) after physician review.
References
- Jastreboff AM, Aronne LJ, Ahmad NN, et al.. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) · New England Journal of Medicine (2022) · PMID 35658024
- Garvey WT, Frias JP, Jastreboff AM, et al.. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2) · Lancet (2023) · PMID 37385275
- Frías JP, Davies MJ, Rosenstock J, et al.. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2) · New England Journal of Medicine (2021) · PMID 34170647
- Inagaki N, Takeuchi M, Oura T, et al.. Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono) · The Lancet Diabetes & Endocrinology (2022) · PMID 35468322
Citations are provided for educational purposes. They do not constitute medical advice. Always discuss any peptide protocol with your prescribing physician.
Tirzepatide (Injectable) near San Francisco
More peptide therapy in San Francisco
More from Weight Loss
Pepti operates in San Francisco, California through licensed physician partnerships. Compounded medications are produced at FDA-registered 503A pharmacies. Treatment decisions are made by your prescribing physician.
— Get started in San Francisco
Ready to start Tirzepatide (Injectable) in San Francisco?
Free assessment. Licensed California physicians. Money-back guarantee if not approved.